Orvana Minerals reports progress in ramping up operations at its Bolivian subsidiary EMIPA's Don Mario plant, processing 17,500 tonnes in October with throughput exceeding 900 tonnes per day late in the month. The company aims to increase throughput to about 1,400 tonnes per day in November and possibly reach 1,700 tonnes per day by December, focusing on optimizing filtration and plant operations. EMIPA filed unaudited Q4 FY2026 financials showing bond covenant ratios outside required thresholds, entering a cure period to restore compliance. The company is working with bondholders on remedial measures while continuing operational improvements.
Orvana Minerals and its Bolivian subsidiary EMIPA are noted here with Pluang's Basic Materials sector context as of Nov 03, 2026 07:01 WIB: Among 83 priced US stocks in this sector, 55 advanced and 27 declined. Key movers include CRH at USD 97.56, up 7.39%, USA Rare Earth Inc. at USD 8.93, down 7.17% with 72% sell order activity, and Southern Copper Corp at USD 178.01, down 7.17% with 59% sell order activity. Typical hold times range from 7 to 63 days.
The Geely E2 (EX2) electric car has reached one million units sold globally within two years of its launch in October 2024, marking rapid market acceptance. It became the world's best-selling car in A&B segments in 2025 and topped sales charts in cou...
AI data centers are expanding beyond traditional land-based locations due to increasing power and space constraints. Companies like Aikido Technologies are exploring floating data centers powered by offshore wind, while Elon Musk's SpaceX plans to de...
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
